{"disease":{"id":"wetamd","name":"wetamd"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02103738","title":"Canadian Treat and Extend Analysis Trial With Ranibizumab","phase":"","overall_status":"COMPLETED","enrollment_count":505,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}